Effectiveness of the New Perilaryngeal Airway in Comparison With the Laryngeal Mask Airway
NCT ID: NCT02439021
Last Updated: 2015-05-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
74 participants
INTERVENTIONAL
2012-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Second Generation LMA Versus Endotracheal Tube in Obese Patients
NCT03748342
The Effects of GMA-TULIP, I-gel, and BlockBuster Laryngeal Mask in Surgeries With Lateral Position Under General Anesthesia
NCT06782841
Laryngeal Mask in Morbid Obesity
NCT04243564
Respiration and The Airway With Supraglottic Airway Devices
NCT03384056
Comparison of Laryngeal Mask and I-gel to Laryngoscope by Novice Operators in Simulated Difficult Airway
NCT02224027
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CobraPLA
Patients will randomly assign to either LMA or Cobra PLATM
COBRA
LMA
Patients will randomly assign to either LMA or Cobra PLATM
LMA
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
COBRA
LMA
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* scheduled for surgery
* being older than 18 years
* Mallampati class I-III and BMI between 25 and 35
Exclusion Criteria
* morbid obese (BMI\>35 kg/m2)
* a known difficult airway
* gastro-oesophageal reflux
* pharyngeal pathology
* emergency operation with full stomach
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Qazvin University Of Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Amir H Pakpour
Assistant Professor, Department of Public Health, Qazvin University of Medical Sciences, Qazvin, Iran.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Amir H Pakpour, PhD
Role: PRINCIPAL_INVESTIGATOR
Qazvin University Of Medical Sciences
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
653
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.